Literature DB >> 6192889

Juvenile xanthogranuloma.

W Cadera, M M Silver, L Burt.   

Abstract

Three infants with juvenile xanthogranuloma are described. Of the two with ocular involvement, one responded to topical corticosteroid and mydriatic therapy and the other to irradiation. The third had skin lesions alone. In the first case new histologic findings were made: lipid vacuoles were observed, by light and electron microscopy, in smooth muscle cells of erector pili and in Schwann cells of small nerves. These findings, along with the detection of lipid vacuoles in mast cells, support the concept that the condition results from local tissue injury that evokes a histioxanthomatous response. Treatment of juvenile xanthogranuloma should be tailored to the individual case and ranges from no active intervention (when there are skin lesions alone or ocular involvement limited to the eyelid or the epibulbar tissue) to a combination of corticosteroid therapy, irradiation and surgery (when there are iris lesions, which rarely resolve spontaneously and may have serious complications). A trial of topical corticosteroid therapy alone in uncomplicated cases is suggested since it was curative in one of the cases presented here.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192889

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  The child with spontaneous recurrent bleeding in the eye.

Authors:  Aparna Rao; Debanand Padhy
Journal:  BMJ Case Rep       Date:  2014-06-13

2.  [Yellowish, prominent tumor of the corneal periphery].

Authors:  M Zimmermann; J Wasielica-Poslednik; W Lisch; N Pfeiffer; A Gericke
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

3.  Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids.

Authors:  I Casteels; J Olver; M Malone; D Taylor
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.